Engerix-B hepatitis B vaccine (recombinant)/Smith, Kline & French.
Engerix-B [Hepatitis B Vaccine (Recombinant)], a product by SmithKline Biologicals, is a noninfectious recombinant DNA hepatitis B vaccine for immunization against infection caused by all known subtypes of hepatitis B virus. It provides a safe and well-tolerated vaccination regimen shown to confer immunity on the basis of anti-HBs antibody responses comparable with those of plasma-derived vaccines.
Swartz
M L
ML
D002986:Clinical Trials as Topic; D017325:Hepatitis B Vaccines; D006801:Humans; D009732:Nursing Care; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines